SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about board meeting intimation

27 Jul 2022 Evaluate
Anuh Pharma has informed that pursuant to the provisions of Regulation 29(1) of the SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015, the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 5th August, 2022, to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2022; and to consider any other matter with the permission of the Chairman.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma Share Price

81.10 -1.70 (-2.05%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×